Your prediction
InVivo Therapeutics Holdings Stock
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for InVivo Therapeutics Holdings stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of InVivo Therapeutics Holdings in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of InVivo Therapeutics Holdings vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| InVivo Therapeutics Holdings | - | - | - | - | - | - | - |
| Theralase Technologies Inc | 0.550% | 12.270% | 4.571% | 56.410% | 107.955% | 26.207% | 11.585% |
| Mauna Kea Tech | -12.330% | 14.614% | 3.040% | 217.391% | 234.155% | -67.388% | -87.141% |
| NetScientific plc | -0.850% | -10.095% | -16.460% | 0.000% | -18.621% | -44.471% | -33.986% |
Comments
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NVIV provided by MarketBeat
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NVIV provided by MarketBeat
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NVIV provided by MarketBeat